Chapters
| Status | Drug name | NICE TAs | Comments |
|---|---|---|---|
|
Aclidinium inhaler (Eklira Genuair) |
For COPD only |
|
|
Aerobika® oscillating positive expiratory pressure (OPEP) device |
Review use after 6 months. |
|
|
|
Aminophylline (Phyllocontin Continus®) | ||
|
|
Aminophylline injection (Phyllocontin Continus®) |
Hospital use only |
|
|
|
Anoro® Ellipta® 55/22mcg (multi dose dry powder inhaler device) |
To be used in line with COPD guidance |
|
|
Bambuterol tablets |
Specialist initiation for severe brittle asthma / CF |
|
|
|
Benralizumab | ||
|
|
Duaklir Genuair |
Aclidinium bromide + formoterol fumarate (Fixed Dose Combination). To be used in in-line with COPD Guidance. |
|
|
|
Formoterol | ||
|
|
Glycopyrronium inhaler |
For COPD only |
|
|
|
Haleraid® | ||
|
|
Ipratropium inhaler | ||
|
|
Ipratropium nebulised | ||
|
|
Kaftrio® |
NHSE commissioned |
|
|
|
Lumacaftor-ivacaftor (Orkambi®) | ||
|
|
Mepolizumab (Nucala®)#3.1 | ||
|
|
Peak flow meter | ||
|
|
Salbutamol inhaler | ||
|
|
Salbutamol injection | ||
|
|
Salbutamol nebulised | ||
|
|
Salbutamol oral | ||
|
|
Salmeterol inhaler |
Prescribe by brand to ensure patients receive the device they are used to. Check licensed indication (differences among brands). Be aware of differences in excipients among the different brands- APC listing of current formulary brands |
|
|
|
Sodium chloride (Bebuliser diluent) | ||
|
|
Spacer device |
Able Spacer® - For use with all pressurised (aerosol) inhalers |
|
|
|
Terbutaline inhaler | ||
|
|
Terbutaline nebulised |
As an alternative to salbutamol nebules if salbutamol is in short supply |
|
|
|
Tezacaftor and ivacaftor (Symkevi®) | ||
|
|
Tezepelumab | ||
|
|
Theophylline (Uniphyllin continus) |
Please refer to the current British National Formulary for advice on monitoring plasma-theophylline level. Theophylline levels may rise when patient stops smoking. |
|
|
|
Tiotropium |
Prescribe by brand to ensure patients receive the device they are used to. Check licensed indication (differences among brands). Be aware of differences in excipients among the different brands - APC listing of current formulary brands |
|
|
|
Tiotropium and Olodaterol (Spiolto® Respimat®) |
For COPD |
|
|
|
Ultibro breezhaler |
Indacaterol maleate and glycopyrronium bromidfe. To be used in line with COPD guidance |
|
|
|
Umeclidinium bromide (Incruse Ellipta®) |
To be used in line with COPD guidance |
